Biotech · Private company · Dedham, MA, US
Chromatan Corporation
Track this companyFree. Adds Chromatan Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II)Fiscal year 2025 · $695.4KNIH RePORTER 5R44GM154572-02 · fetched Nov 12, 2026
- Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II)Fiscal year 2024 · $1.3MNIH RePORTER 1R44GM154572-01A1 · fetched Nov 12, 2026
- Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II)Fiscal year 2024 · $214.5KNIH RePORTER 3R44GM154572-01A1S1 · fetched Nov 12, 2026